Consti’s Q2 results beat our estimates for both net sales and EBIT.
Finnair’s Q2 EBIT missed our estimate due to slight negative surprises in revenue and costs.
- 3% organic growth to accelerate to 18-16% H2'24e - 22% adj.
- We cut '24e sales and EBITDA by 2% and 21%, respectively - Headwinds for Aurdel likely to persist ...
Vitrolife delivered a surprising organic growth recovery with 4% organic growth and even if there wa...
Hansa’s launch progress continues in Q2. The net sales include provisions reflecting an extended per...
Redeye comments on last week’s positive decision for patent ‘879.
Redeye states that with improved growth rates for recurring revenues, Truecaller is quickly becoming...
- Sales decline 6% y-o-y as EBIT remains at break-even - Weak restaurant and hotel market hamper NW&...
Redeye retains its positive view of Sdiptech following a Q2 report that met our expectations.
- Sales grew 4%, but adj. EBITA margin down to 6.8% (7.
- Q2'24 results due 20 August - 142% growth y-o-y for Catalyst, +9.
Redeye sustains its positive view of CombinedX despite a weak Q2 report, with margins substantially ...
Redeye’s view on the Q2 report. The organic growth was decent, while the gross margin development co...
Redeye provides a first take on Advenica’s second quarter of the year.
- Sales +1% vs. ABGSCe (-5% y-o-y), EBIT +4% vs. ABGSCe - Ework continues to see recovery in demand ...
- Strong growth, adj. EBIT +14% vs cons but orders -8% vs cons - Activity level to remain high for m...
- Sales -14% vs. ABGSCe, EBIT SEK 0m vs. ABGSCe 2m - NW&FT drives sales miss due to restaurant marke...
Innofactor’s Q2 profitability was weak, although mostly due to one-offs.
Finnair’s Q2 results were somewhat softer than estimated as the EUR 44m comparable EBIT missed estim...
